Transgene Biotek Ltd

NSE: TRABI · BSE: 526139 · Healthcare · 14 announcements

Share price: ₹2.30
Market cap: ₹17.43 Cr
Revenue (annual): ₹0.21 Cr
Net profit (annual): ₹-1.65 Cr
P/E (TTM): -10.8×Sector 53.1×
Promoter holding: 23.64%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 2 Other Announcement 1 Financial Results 1 Capital Structure Change 1 Board Meeting Date 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

15 Jul 2026 17:05 IST BSE

Capital Structure Change

Transgene Biotek Capital Structure Change

Transgene Biotek allotted 1,00,00,000 equity shares worth Rs.10 Crore to its promoter on a preferential basis. The allotment converts existing unsecured promoter loans into equity.

Value: ₹10.00 Cr

Read the filing ↗